[en] The HER2 proto-oncogene product is overexpressed in 30% of breast cancers, and this correlates with poor prognosis. Increased levels of HER2 mRNA in breast cancer cell lines result from increased gene transcription. We report the identification of a new 17-bp-long cis sequence located between positions -506 and -489 from the transcription start site. This sequence is recognized by a trans-activating factor that we tentatively named HER2 transcription factor (HTF). This factor, involved in the increased transcription of the HER2 gene in the BT-474 mammary tumor cells, has a molecular weight of about Mr 50,000. HTF can also bind, but with a lower affinity, to a related cis sequence present in the epidermal growth factor receptor promoter. Interestingly, the HTF binding activity is high in nuclear extracts from several mammary tumor cells overexpressing the HER2 gene.
Akiyama, T., Sudo, C., Ogawara, H., Toyoshima, K., and Yamamoto, T. The product of the human c-erbB-2 gene: a 185-kDa glycoprotein with tyrosine kinase activity. Science (Washington DC), 232: 1644-1646, 1986.
Karunagaran, D., Tzahar. E., Beerli, R. R., Chen, X., Graus-Porta, D., Ratzkin, B. J., Seger, R., Hynes, N. E., and Yarden, Y. ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancers. EMBO J., 15: 254-264, 1996.
Tzahar, E., Waterman, H., Chen, X., Levkowitz, G., Karunagaran, D., Lavi, S., Ratzkin, B. J., and Yarden, Y. A hierarchical network of interreceptor interactions determines signal transduction by neu differentiation factor/neuregulin and epidermal growth factor. Mol. Cell. Biol., 16: 5276-5287, 1996.
Press, M., Cordon-Cardo, C., and Slamon, D. Expression of the HER-2/neu proto-oncogene in normal human adult and fetal tissues. Cancer Res., 54: 4193-4199, 1990.
Slamon, D. J., Godolphin, W., Jones, L. A., Holt, J. A., Wong, S. G., Keith, D. E., Levin, W. J., Stuart, S. G., Udove, J., Ullrich, A., and Press, M. F. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science (Washington DC), 244: 707-710, 1989.
Kraus, M., Popescu, C., Amsbaugh, S., and King, C. Overexpression of the EGF receptor-related proto-oncogene erbB2 in human mammary tumor cell lines by different molecular mechanisms. EMBO J., 6: 605-610, 1987.
Slamon, D. J., Clark, G. M., Wong, S. G., Levin, W. J., Ullrich, A., and McGuire, W. L. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science (Washington DC), 235: 177-182, 1987.
Gusterson, B. A., Gelber, R. D., Goldhirsch, A., Price, K. N., save-Soderborgh, J., Anbazhagan, R., Styles, J., Rudenstam, C. M., Golouh, R., Reed, R., Martinez-Tello, F., Tiltman, A., Torhorst, J., Grigolato, P., Bettelheim, R., Neville, A. M., Burki, K., Castiglione, M., Collins, J., Lindtner, J., and Senn, H. J. Pronostic importance of c-erbB-2 expression in breast cancer. J. Clin. Oncol., 10: 1049-1056, 1992.
Wright, C., Nicholson, S., Angus, B., Sainsbury, J. R., Farndon, J., Cairns, J., Harris, A. L., and Home, C. H. Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer. Br. J. Cancer, 65: 118-124, 1992.
Pasleau, F., Grooteclaes, M., and Gol-Winkler, R. Expression of the c-erbB2 gene in the BT-474 human mammary tumor cell line: measurement of the c-erbB2 mRNA half-life. Oncogene, 8: 849-854, 1993.
Hollywood, D. and Hurst, H. A novel transcription factor, OB2-1, is required for overexpression of the proto-oncogene c-erbB-2 in mammary tumor cell lines. EMBO J., 12: 2369-2375, 1993.
Miller, S., Suen, T-C., Sexton, T., and Hung, M-C. Mechanisms of deregulated HER2/neu expression in breast cancer cell lines. Int. J. Oncol., 4: 599-608, 1994.
Bosher, J. M., Williams, T., and Hurst, H. C. The developmentally regulated transcription factor AP-2 is involved in the c-erbB-2 overexpression in human mammary adenocarcinoma. Proc. Natl. Acad. Sci. USA, 92: 744-747, 1995.
Bosher, J., Totty, N., Hsuan, J., Williams, T., and Hurst, H. A family of AP-2 proteins regulates c-erbB-2 expression in mammary carcinoma. Oncogene, 13: 1701-1707, 1996.
Benz, C. C., O'Hagan, R. C., Richter, B., Scott, G. K., Chang, C-H., Xiong, X., Chew, K., Ljung, B-M., Edgerton, S., Thor, A., and Hassel, J. A. HER2/neu and the Ets transcription factor PEA3 are coordinately upregulated in human breast cancer. Oncogene, 15: 1513-1525, 1997.
Scott, G., Daniel, J., Xiong, X., Maki, R., Kabat, D., and Benz, C. Binding of an ETS-relaled protein within the DNase I hypersensitive site of the HER2/neu promoter in human breast cancer cells. J. Biol. Chem., 269: 19848-19858, 1994.
Chen, Y., and Gill, G. A heterodimeric nuclear protein complex binds two palindromic sequences in the proximal enhancer of the human erbB-2 gene. J. Biol. Chem., 271: 5183-5188, 1996.
Chen, Y., Fischer, W. H., and Gill, G. N. Regulation of the ERBB-2 promoter by RBPJκ and NOTCH. J. Biol. Chem., 272: 14110-14114, 1997.
Grooteclaes, M., Pasleau, F., Dijkmans, H., Berzi, P., Albert, A., and Winkler-Gol, R. The 6-kb c-erbB2 promoter contains positive and negative regulatory elements functional in human mammary cell lines. Cancer Res., 54: 4193-4199, 1994.
Dignam, J. D. Preparation of extracts from higher eucaryotes. Methods Enzymol., 182: 194-203, 1990.
Kageyama, R., Merlino, G. T., and Pastan, I. A transcription factor active on the epidermal growth factor receptor gene. Proc. Natl. Acad. Sci. USA, 85: 5016-5020, 1988.
Williams, T., and Tjian, R. Analysis of the DNA-binding and activation properties of the human transcription factor AP-2. Genes Dev., 5: 670-682, 1991.
Masson, M., Rolli, V., Dantzer, F., Trucco, C., Schreiber, V., Fribourg, S., Molinete, M., Ruf, A., Miranda, E. A., Niedergang, C., Hunting, D., Gowans, B., Shulz, G. E., Ménissier de Murcia, J., and de Murcia, G. Poly(ADP-ribose) polymerase: structure-function relationship Biochimie, 77: 456-461, 1995.
Pasleau, F., Grooteclaes, M., and Gol-Winkler, R. Using a molecular titration assay to quantitate and characterize the c-erbB2 mRNA synthesized in human mammary adenocarcinoma cell lines. Arch. Int. Physiol. Biochem., 98: 40, 1990.
Johnson, A. C. Activation of epidermal growth factor receptor gene transcription by phorbol 12-myristate 13-acetate is mediated by activator protein 2. J. Biol. Chem., 271: 3033-3038, 1996.
